MALIGNANT TUMORS
Clinical trials for MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope drug enters human testing for Tough-to-Treat cancers
Disease control Recruiting nowThis is the first study in people testing a new drug called LM-350 for advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also check for early signs that the dru…
Matched conditions: MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New Two-Drug attack on cancer shows promise in early testing
Disease control Recruiting nowThis study is testing whether combining two immunotherapy drugs—LBL-007 and tislelizumab—is safe and effective for treating various cancers. Researchers will enroll up to 490 adults with solid tumors to determine the best dose and see how well the combination shrinks tumors. The …
Matched conditions: MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New scan seeks to spot cancer more clearly
Diagnosis Recruiting nowThis early study is testing a new type of PET scan (using a tracer called 68Ga-FL-031) to see if it can help doctors better find, identify, and determine the stage of certain cancers. It will involve about 10 adults with suspected or confirmed cancers like small cell lung cancer,…
Matched conditions: MALIGNANT TUMORS
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Mar 25, 2026 14:09 UTC